Farallon Capital Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $373M | Sell |
|
|||||
|
2021
Q2 | $314M | Sell |
|
|||||
|
2021
Q1 | $353M | Hold |
|
|||||
|
2020
Q4 | $333M | Hold |
|
|||||
|
2020
Q3 | $293M | Buy |
|
|||||
|
2020
Q2 | $200M | Sell |
|
|||||
|
2020
Q1 | $195M | Buy |
|
|||||
|
2019
Q4 | $106M | Sell |
|
|||||
|
2019
Q3 | $94.8M | Buy |
|
|||||
|
2019
Q2 | $97.6M | Hold |
|
|||||
|
2019
Q1 | $111M | Buy |
|
|||||
|
2018
Q4 | $91.5M | Buy |
|
|||||
|
2018
Q3 | $105M | Buy |
|
|||||
|
2018
Q2 | $68M | Hold |
|
|||||
|
2018
Q1 | $54.8M | Buy |
|
|||||
|
2017
Q4 | $46.2M | Buy |
|
|||||
|
2017
Q3 | $35.9M | Buy |
|